Home › NDC Lookup › RxCUI directory › RxCUI 2606516

Leuprolide acetate 22.5 MG Injection — RxCUI 2606516

Name: Leuprolide acetate 22.5 MG Injection (RxCUI 2606516)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2606516 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2606516

Official nameLeuprolide acetate 22.5 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped2

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Leuprolide Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It depends on the product prescribed. Fensolvi is used for children 2 and older who are going through puberty too early — a condition called central precocious puberty. Products li...
What exactly is leuprolide injection used for?
This is called a tumor flare, and it's actually expected. In the first one to two weeks, testosterone levels temporarily rise before the medication brings them down. For men with p...
Why might symptoms get worse right after starting the injection?

📖 Read our full Leuprolide Injection guide →

🕸️ Concept Web — How Leuprolide acetate 22.5 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Leuprolide acetate 22.5 MG Injection RxCUI 2606516 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Leuprolide 42375 IN
- Leuprolide acetate 203217 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Lutrate 2709443 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Leuprolide Injection 2606515 SCDF
- Leuprolide acetate Injection 2648419 SCDFP
- Leuprolide Injectable Product 1163443 SCDG
- Leuprolide acetate Injectable Product 2659197 SCDGP
- Leuprolide Injection [Lutrate] 2709446 SBDF
- Leuprolide acetate Injection [Lutrate] 2709447 SBDFP
- Lutrate Injectable Product 2709445 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Leuprolide acetate 22.5 MG 2606514 SCDC
- Leuprolide acetate 22.5 MG Injection [Lutrate] 2709448 SBD
- Leuprolide acetate 22.5 MG [Lutrate] 2709444 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Leuprolide acetate 22.5 MG SCDC · 2606514
Leuprolide Injection SCDF · 2606515
Leuprolide acetate Injection SCDFP · 2648419
Leuprolide Injectable Product SCDG · 1163443
Leuprolide acetate Injectable Product SCDGP · 2659197

Brand-Name Concepts

Leuprolide acetate 22.5 MG Injection [Lutrate] SBD · 2709448
Leuprolide acetate 22.5 MG [Lutrate] SBDC · 2709444
Leuprolide Injection [Lutrate] SBDF · 2709446
Leuprolide acetate Injection [Lutrate] SBDFP · 2709447
Lutrate Injectable Product SBDG · 2709445
Lutrate BN · 2709443

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 2606516 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
69097-0909-50	1 KIT in 1 CARTON (69097-909-50) * 2 mL in 1 VIAL, SINGLE-...	LEUPROLIDE ACETATE DEPOT	CIPLA USA INC.	2022-07-15
83831-0134-01	1 KIT in 1 CARTON (83831-134-01) * 2 mL in 1 VIAL, SINGLE-...	LUTRATE DEPOT	Avyxa Pharma, LLC	2025-03-26

Observed labelers: Avyxa Pharma, LLC (1) · CIPLA USA INC. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1954	Inj leu acet lutr dpt 7.5 mg	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.